Literature DB >> 23412903

Reference intervals for serum thyroid hormones in preterm hospitalized infants.

Lina Zhu1, Xiaoying Zhang, Xiyu He, Xiao Yang, Yan Wang, Chunzhi Wang, Zhichun Feng.   

Abstract

OBJECTIVE: In our study, the reference intervals of serum thyroid hormones were established in 247 hospitalized preterm infants from 28 to 36 weeks of gestation at 8-15 postnatal days. The thyroid hormones were serum triiodothyronine (T3), free triiodothyronine (FT3), thyroxine (T4), free thyroxine (FT4), and thyrotropin (TSH).
METHODS: Electrochemiluminescence immunoassay was used to examine the thyroid hormone levels of serum samples from 247 preterm infants, who were grouped on sampling by gestational age. SPSS 16.0 was used to calculate the population-based reference intervals, in comparison to the manufacturer's suggested reference intervals.
RESULTS: Kruskal-Wallis H tests could not determine the difference in TSH levels among groups, which allowed us to develop a single interval for the study population. ANOVA determined the differences in T3, FT3, T4, and FT4 levels among groups, which allowed us to define reference intervals for preterm infants according to their gestational age.
CONCLUSION: Developed reference intervals are useful for clinical diagnosis; however, there is a lack of consensus. These values could be used to assess the thyroid status of preterm infants and provide a foundation for clinical therapy. The results emphasized the importance of establishing gestational age-based reference intervals for the clinical laboratory.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23412903     DOI: 10.1515/jpem-2012-0277

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  1 in total

1.  Nomogram-based evaluation of thyroid function in appropriate-for-gestational-age neonates in intensive care unit.

Authors:  E Y Imamoglu; T Gursoy; M Hayran; G Karatekin; F Ovali
Journal:  J Perinatol       Date:  2014-10-09       Impact factor: 2.521

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.